Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular Disorders: https://mms.businesswire.com/media/20191210005404/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg
Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular Disorders


Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), today announced that Lineage and its subsidiary, Cell Cure Neurosciences Ltd., have entered into an exclusive worldwide collaboration

U.K. Companies Turning to Intelligent Automation to Solve Business Challenges from Pandemic, Brexit: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
U.K. Companies Turning to Intelligent Automation to Solve Business Challenges from Pandemic, Brexit


Many British enterprises have been investing in intelligent business automation even as overall U.K. IT spending declines, according to a new research report published today by Information Services

German Firms Expand Use of Intelligent Automation After Pandemic Shakes Up Ways of Doing Business: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
German Firms Expand Use of Intelligent Automation After Pandemic Shakes Up Ways of Doing Business


German enterprises are increasing their use of intelligent automation, partly in response to disruptions from the COVID-19 pandemic, as the country joins in a European technology and business

NTT WEST Group Selects HPE GreenLake to Launch New Portfolio of Hybrid Cloud Services: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24510/Hewlett_Packard_Enterprise_logo.svg.png
NTT WEST Group Selects HPE GreenLake to Launch New Portfolio of Hybrid Cloud Services


Hewlett Packard Enterprise (NYSE: HPE) today announced that NTT Business Solutions, a member company of NTT WEST Group, Japan’s leading network and system integrator has selected the HPE GreenLake

SunMirror AG ('the Company') Announces Launch of Offer to Acquire Latitude 66 Cobalt Limited
SunMirror AG ('the Company') Announces Launch of Offer to Acquire Latitude 66 Cobalt Limited


Publication of inside information pursuant to Article 17 of the EU Market Abuse Regulation (MAR)



Further to the announcement made by the Company on 26 August 2021, the Company announces that on

Heidelberger Druckmaschinen AG: Heidelberg and VGP develop modern HEI-TECH industrial park at Wiesloch/Walldorf site: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24109/Heidelberg-Logo.svg.png
Heidelberger Druckmaschinen AG: Heidelberg and VGP develop modern HEI-TECH industrial park at Wiesloch/Walldorf site
Heidelberger Druckmaschinen AG: Heidelberg and VGP develop modern HEI-TECH industrial park at Wiesloch/Walldorf site
Lysogene Awarded Innovation Passport by the UK MHRA for the GM1 Gangliosidosis Program
Lysogene Awarded Innovation Passport by the UK MHRA for the GM1 Gangliosidosis Program


Regulatory News:



Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announced today that the Medicines and

Sensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent Director: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent Director


Regulatory News:



Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and

ADNOC Drilling and Helmerich & Payne Enter Framework Agreement to Enable Growth and Unlock Efficiencies: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24508/Helmerich___Payne_logo.png
ADNOC Drilling and Helmerich & Payne Enter Framework Agreement to Enable Growth and Unlock Efficiencies


ADNOC Drilling Company PJSC (“ADNOC Drilling” or the “Company”) (ADX symbol: ADNOCDRILL / ISIN: AEA007301012) and Helmerich & Payne, Inc. (“H&P”) (NYSE: HP) today jointly announced the finalization

Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211219005059/en/



AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR



Vifor

DGAP-News: Vonovia SE: 211220_Vonovia with top position in S&P Global sustainability ranking: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23633/Vonovia_Logo.svg.png
DGAP-News: Vonovia SE: 211220_Vonovia with top position in S&P Global sustainability ranking
DGAP-News: Vonovia SE: 211220_Vonovia with top position in S&P Global sustainability ranking
EQS-News: New Director for Hotelbusiness Zug AG
EQS-News: New Director for Hotelbusiness Zug AG
EQS-News: New Director for Hotelbusiness Zug AG
Eva Berneke Appointed Chief Executive Officer of Eutelsat: https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
Eva Berneke Appointed Chief Executive Officer of Eutelsat


Regulatory News:



The Board of Directors of Eutelsat Communications (Euronext Paris: ETL) is pleased to announce the appointment of Eva Berneke as Chief Executive Officer, with effect from 1st

Newmont Corporation Announces Early Results of the Tender Offers for Any and All of its 3.700% Notes due 2023 and Goldcorp’s 3.700% Notes due 2023 and Related Consent Solicitations: https://assets2.sharewise.com/attachment/file/24654/263px-Newmont_logo.svg.png
Newmont Corporation Announces Early Results of the Tender Offers for Any and All of its 3.700% Notes due 2023 and Goldcorp’s 3.700% Notes due 2023 and Related Consent Solicitations


Newmont Corporation (NYSE: NEM, TSX: NGT) (Newmont or the Company) announced today the early results of the previously announced offers to purchase for cash any and all of the outstanding (i)

Granite REIT Declares Distribution for December 2021: https://mms.businesswire.com/media/20191217005844/en/763597/5/Granite_REIT_rgb.png.jpg
Granite REIT Declares Distribution for December 2021


Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of

Albany International Declares Dividend: https://mms.businesswire.com/media/20210513005937/en/878052/5/AILogoJPGFormat.jpg
Albany International Declares Dividend


The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.21 per share on the Company’s Class A and Class B Common Stock, payable January 10, 2022

D.R. Horton, Inc. to Release 2022 First Quarter Earnings on February 2, 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24360/D._R._Horton_logo.png
D.R. Horton, Inc. to Release 2022 First Quarter Earnings on February 2, 2022


D.R. Horton, Inc. (NYSE:DHI), America’s Builder, announced today that the Company will release financial results for its first quarter ended December 31, 2021 on Wednesday, February 2, 2022 before

DGAP-News: BP p.l.c.: Transaction in Own Shares: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23826/BP_logo.svg.png
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
Transgene Announces Investor Meetings for January 2022: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene Announces Investor Meetings for January 2022


Regulatory News:



TRANSGENE (Paris:TNG) today announces that Management will participate in the upcoming investor events set out below.



Transgene will meet institutional investors at the 11th

Newmont Corporation Announces Pricing of the Tender Offers for its 3.700% Notes due 2023 and Goldcorp’s 3.700% Notes due 2023: https://assets2.sharewise.com/attachment/file/24654/263px-Newmont_logo.svg.png
Newmont Corporation Announces Pricing of the Tender Offers for its 3.700% Notes due 2023 and Goldcorp’s 3.700% Notes due 2023


Newmont Corporation (NYSE: NEM, TSX: NGT) (Newmont or the Company) announced today the pricing terms of the previously announced offers (each, a “Tender Offer” and, together, the “Tender Offers”)

Keysight’s Participation in O-RAN Global Plugfest 2021 Enables Ecosystem to Speed Open RAN Technology Development and Specifications Maturity: https://mms.businesswire.com/media/20191105005173/en/754303/5/Keysight_Signature_Pref_Color.jpg
Keysight’s Participation in O-RAN Global Plugfest 2021 Enables Ecosystem to Speed Open RAN Technology Development and Specifications Maturity


Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world

Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Alzamend Neuro Announces Positive Topline Data from Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s: https://mms.businesswire.com/media/20210804005491/en/835633/5/Alzamend_Neuro_-_Corporate_Logo_with_R_mark_10262020.jpg.jpg
Alzamend Neuro Announces Positive Topline Data from Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s


Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and

Synalloy Announces Closing of Highly Successful $10 Million Rights Offering
Synalloy Announces Closing of Highly Successful $10 Million Rights Offering


Synalloy Corporation (Nasdaq: SYNL) (“Synalloy” or the “Company”), an industrials company focused on the production and distribution of piping, tubing and specialty chemicals, today announced the

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.